Last edition
News about "Official Action Indicated Status"
Aurobindo Pharma Unit Receives US FDA Warning Letter; No Impact on US Supplies
Aurobindo Pharma’s Eugia Pharma Specialities has received a US FDA warning letter for its Telangana facility, while the company said existing US supplies remain unaffected.
Official Action Indicated Status | 14/08/2026 | By News Bureau | 222
FDA Flags Lupin's Pithampur Manufacturing Facility with Official Action Indicated Status
Lupin stated that it is actively engaging with the U.S. regulator and remains committed to maintaining full compliance with current Good Manufacturing Practice (cGMP) standards across all its manufacturing sites.
Official Action Indicated Status | 06/10/2025 | By Darshana | 667
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy